Immunovant
IMVT
#3621
Rank
A$4.39 B
Marketcap
$25.88
Share price
8.03%
Change (1 day)
-45.23%
Change (1 year)

Market capitalization of Immunovant (IMVT)

Market cap: A$4.39 Billion

As of April 2025 Immunovant has a market cap of A$4.39 Billion. This makes Immunovant the world's 3621th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Immunovant from 2019 to 2025

End of year Market Cap

Year Marketcap Change
2025A$4.39 B-23.94%
2024A$5.77 B-35.39%
2023A$8.94 B165.48%
2022A$3.36 B149.32%
2021A$1.35 B-77.02%
2020A$5.88 B374.66%
2019A$1.23 B

End of Day market cap according to different sources

On Apr 2nd, 2025 the market cap of Immunovant was reported to be:

A$4.39 Billion
by Nasdaq info icon info icon
A$4.39 Billion
by CompaniesMarketCap info icon info icon
A$4.39 Billion
by Yahoo Finance info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
A$0.64 B-85.28%๐Ÿ‡บ๐Ÿ‡ธ USA